General Info

Our Mission Cure chemotherapy-induced peripheral neuropathy (CIPN). Our revolutionary invention directly targets the root cause of CIPN. 70% Of chemotherapy patients develop peripheral neuropathy 50% Of chemotherapy patients suffer from irreversible nerve damage 30% Of chemotherapy patients delay or terminate treatment due to severe neuropathy